Want to join the conversation?
Biotechnology company $GILD said that it it has submitted a New Drug Application (NDA) to the FDA for tenofovir alafenamide (TAF) 25 mg, a once-daily drug for treating adults with chronic hepatitis B virus (HBV) infection, a condition of the liver. $GILD plans to submit a regulatory application for TAF in the EU in the 1Q16.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.